Nevertheless, other genes, such as MRE11, BARD1, POT1, BUB1B, POLE2, BRF1, IL12RB1, PTPN12, or the epigenetic alteration of PTPRJ, show promising evidence that supports their involvement in CRC predisposition (Figure 1). This evidence concerns the gene PTPRJ and colorectal carcinoma.